NCT07030569
- Conditions
- Breast Cancer, Breast Cancer Metastatic, Breast Cancer Stage IV, +18 more
- Locations
-
- Fondazione IRCCS Istituto Nazionale Tumori Milan, Italy
Clinical trial condition
HER2 + Breast Cancer
Explore clinical trials studying HER2 + Breast Cancer. Study availability and eligibility vary by location and protocol.
22 public trials
11 recruiting studies
HER2 + Breast Cancer trial results
Not yet recruiting
A Phase II Study of HLX22 in Combination With Trastuzumab and Chemotherapy in HER2-Positive Locally Advanced or Metastatic Breast Cancer Patients
NCT07824869
- Conditions
- Breast Diseases, Breast Neoplasms, HER2 + Breast Cancer, +4 more
- Locations
-
Not specified
Not yet recruiting
Trastuzumab Rezetecan Followed by Pyrotinib, and Trastuzumab Combined With Capecitabine as First-line Treatment for Advanced HER2-positive Breast Cancer
NCT07766772
- Conditions
- Advanced Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
- Locations
-
- Fujian Cancer Hosptial Fuzhou, Fujian, China
Not yet recruiting
Circulating Tumor DNA Dynamics to Optimize Neoadjuvant Therapy in HER2-Positive and Triple-Negative Breast Cancer
NCT07662252
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
- Locations
-
Not specified
NCT07560475
- Conditions
- Advanced Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
- Locations
-
- Tianjin Medical University Cancer Insititute and Hospital Tianjin, China
Not yet recruiting
A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of HLX319 vs. EU-Phesgo® in the Neoadjuvant Therapy of HER2-Positive Early or Locally Advanced Breast Cancer
NCT07601620
- Conditions
- Breast Diseases, Breast Neoplasms, HER2 + Breast Cancer, +4 more
- Locations
-
Not specified
Not yet recruiting
Pragmatic Study to Optimize Neoadjuvant Treatment and Surgical De-escalation in HR+/HER2- Early Breast Cancer Using Oncotype DX and Abemaciclib
NCT07428018
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
- Locations
-
- Istituto di Ricerche Farmacologiche Mario Negri IRCCS Milan, MI, Italy
Not yet recruiting
A Phase II/III Clinical Study to Evaluate the Efficacy and Safety of HLX87in Combination With HLX22 or Pertuzumab in the Neoadjuvant Therapy of HER2-Positive Bresat Cancer
NCT07294534
- Conditions
- Breast Diseases, Breast Neoplasms, HER2 + Breast Cancer, +4 more
- Locations
-
Not specified
NCT07129187
- Conditions
- Breast Diseases, Breast Neoplasms, Early Breast Cancer, +7 more
- Locations
-
Not specified
Not yet recruiting
Efficacy of TQB2102 Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer.
NCT07136974
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
- Locations
-
- Henan cancer hospital Zhengzhou, Henan, China